Editorial comment

• Impact of aortic valve calcification on TAVI. Should we rethink existing concepts?

  Alberto Alperi, Raquel del Valle, Pablo Avanzas

  Rev Esp Cardiol. 2025;78:519-20

• VA-ECMO and ventricular unloading. A game-changer or just a glimmer of hope?

  Aitor Uribarri, Eduard Ródenas-Alesina, Ignacio Ferreira-González

  Rev Esp Cardiol. 2025;78:504-6

• Clinical guidelines and quality indicators. Do we practice what we preach?

  Finn Åkerström, Emma Svennberg

  Rev Esp Cardiol. 2025;78:401-3

• ApoB and prognosis of patients with chronic coronary syndrome

  Alberto Cordero, Rosa Fernández Olmo

  Rev Esp Cardiol. 2025;78:414-5

• Everything flows, nothing stays... or does it?

  Carlos Nicolás Pérez-García, Inés García-Lunar

  Rev Esp Cardiol. 2025;78:34-6

• Pregnancy in women with genetic variants of dilated cardiomyopathy

  Luis Ruiz-Guerrero, Francisco González-Vílchez

  Rev Esp Cardiol. 2025;78:10-1

• Charting the path: from the defibrillator vest to a reborn heart

  Víctor Castro-Urda

  Rev Esp Cardiol. 2024;77:1058-9

• Acute pericarditis: when is an exhaustive search of causes needed?

  José Rozado

  Rev Esp Cardiol. 2024;77:1062-4

• Is DOAC the preferred oral anticoagulation therapy after TAVI?

  Gabriela Tirado-Conte, Ángel Sánchez-Recalde, José Luis Zamorano

  Rev Esp Cardiol. 2024;77:985-6

• Coronary physiology: an essential diagnostic tool beyond obtaining a cutoff point

  Ramón López-Palop, Pilar Carrillo, Eduardo Pinar

  Rev Esp Cardiol. 2024;77:896-8

• Proposal for a model of care for emergency pacemaker implantation

  Moisés Rodríguez-Mañero, José R. González-Juanatey

  Rev Esp Cardiol. 2024;77:910-1

• Obesity in Spain: an open book that must be read

  Emilio Ortega Martínez de Victoria, Adriana Pané Vila, Amanda Jiménez Pineda

  Rev Esp Cardiol. 2024;77:819-20

• Unhealthy lifestyle and cardiovascular risk profile: a concern in working young adults in Spain

  Dimelza Osorio-Sánchez

  Rev Esp Cardiol. 2024;77:832-4

• “Spatiotemporal Dispersion Reloaded”? “CFAE Resurrections”? A new installment in the saga of subjective identification of atrial fibrillation drivers

  Jorge G. Quintanilla

  Rev Esp Cardiol. 2024;77:734-6

• Infective endocarditis in 21st century Spain: a persistent therapeutic challenge in a changing scenario

  Arístides de Alarcón

  Rev Esp Cardiol. 2024;77:747-9

• Predicting the development of heart failure in patients with atrial fibrillation

  Daniel Enríquez-Vázquez, María G. Crespo-Leiro, Eduardo Barge-Caballero

  Rev Esp Cardiol. 2024;77:720-2

• OCT-guided versus IVUS-guided percutaneous coronary intervention in patients with acute myocardial infarction. Do we have a winner?

  Andrea Ruberti, Mauro Echevarría-Pinto, Ander Regueiro

  Rev Esp Cardiol. 2024;77:618-20

• Primary mitral regurgitation treated with transcatheter edge-to-edge repair. Does transthoracic echocardiography provide prognostic information?

  Dolores Mesa, Rafael González-Manzanares, Manuel Pan

  Rev Esp Cardiol. 2024;77:632-3

• Cardiovascular magnetic resonance in the working diagnosis of MINOCA: the sooner, the better?

  Rocío Párraga, Carlos Real, Rodrigo Fernández-Jiménez

  Rev Esp Cardiol. 2024;77:524-6

• Rest in PEACE?

  Raban V. Jeger, Gregor Fahrni

  Rev Esp Cardiol. 2024;77:537-8